首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

2107444

蛋白質生物標記市場：按生物標記類型、應用、最終用戶和地區分類

Protein Biomarkers Market, By Biomarker Type, By Application, By End User, By Geography

出版日期: 2026年07月24日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，蛋白質生物標記市場規模將達到 99.259 億美元，到 2033 年將達到 176.866 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	99.259億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.60%	2033年市場規模預測：	176.866億美元

蛋白質生物標記是存在於體液和組織中的分子，研究人員、科學家和臨床醫生可以利用它們來測量組織功能、監測疾病進展以及評估正常和異常功能和治療反應。蛋白質生物標記在癌症、心血管疾病和神經系統疾病的檢測和診斷，以及患者分層、感染疾病和治療方面，都提供了寶貴的策略。

由於蛋白質體學、質譜和次世代定序等技術的廣泛應用以及人工智慧數據分析的日益普及，全球蛋白質生物標記市場正經歷顯著成長。該市場涵蓋生物標記發現和檢驗平台、診斷試劑、試劑和生物資訊解決方案，服務於製藥公司、生物技術公司、臨床實驗室、受託研究機構(CRO) 和學術研究機構，同時也為精準醫療的日益發展提供了支持。

市場動態

全球蛋白質生物標記市場受癌症、心血管疾病、糖尿病和神經退化性疾病發病率不斷上升的驅動，導致對快速早期檢測和診斷的需求日益成長。精準醫療實踐的進步、多重免疫檢測和質譜等新技術的湧現以及蛋白質組學的進展，都在加速蛋白質生物標記檢測的開發和應用。生物標記發現研究投入的增加，進一步加速了基於蛋白質生物標記的診斷方法的開發和商業化。

然而，該市場面臨許多限制因素，包括生物標記發現和檢驗的高成本、嚴格的監管要求以及檢測標準化和可重複性方面的問題。儘管如此，液態生物檢體的日益普及、人工智慧和機器學習在生物標記發現中的應用，以及即時診斷技術的日益普及，都將為蛋白質生物標記市場創造新的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球蛋白質生物標記市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份全球蛋白質生物標記市場報告面向產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球蛋白質生物標記市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Merck KGaA
- QIAGEN NV
- Bio-Rad Laboratories, Inc.
- Revvity, Inc.
- Bio-Techne Corporation
- Quanterix Corporation

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9842

Protein Biomarkers Market is estimated to be valued at USD 9,925.9 Mn in 2026 and is expected to reach USD 17,686.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9,925.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.60%	2033 Value Projection:	USD 17,686.6 Mn

Protein biomarkers are molecules in bodily fluid or tissue that help researchers, scientists, or clinicians measure the functional state of a tissue, monitor disease progression, or indicate normal/abnormal function or response to treatment. Protein biomarkers offer a valuable strategy for cancer, cardiovascular and neurological disorder detection and diagnoses, patient stratification, infectious disease, and therapy.

The global protein biomarkers market is growing significantly as a result of recent developments and adoption of technologies such as proteomics, mass spectrometry, and next generation sequencing and the increase in the application of AI driven data analytics. The market consists of biomarker discovery and validation platforms, diagnostic assays, reagents and bioinformatics solutions, and it serves pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations, and academic research institutions, while also supporting the growing use of precision medicine.

Market Dynamics

The global protein biomarkers market is driven by increasing occurrence of cancer, cardiovascular disorders, diabetes and neurodegenerative conditions leading to a demand for quick and early detection and diagnosis. The development and launch of protein biomarker tests is gaining traction with enhanced precision medicine practices and the emergence of novel technologies including multiplex immunoassays, mass spectrometry, and the progress of proteomic technologies. Growing expenditure in biomarker discovery research are further accelerating the development and commercialization of protein biomarker-based diagnostics.

However, a number of constraints are present in the market, such as high costs associated with biomarker discovery and validation, stringent regulatory requirements, and issues related to assay standardization and reproducibility. Nevertheless, expanding applications of liquid biopsy, integration of AI and machine learning in biomarker discovery, and increasing adoption of point-of-care diagnostics will offer new opportunities for growth in protein biomarkers market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global protein biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies, Inc., Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Revvity, Inc., Bio-Techne Corporation, and Quanterix Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global protein biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein biomarkers market

Market Segmentation

Biomarker Type Insights (Revenue, USD Mn, 2021 - 2033)
Oncology Protein Biomarkers
Cardiac Protein Biomarkers
Inflammatory and Sepsis Protein Biomarkers
Neurology Protein Biomarkers
Autoimmune Protein Biomarkers
Metabolic Protein Biomarkers
Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
Biomarker Discovery and Validation
Drug Discovery and Clinical Trial Support
Assay Development
Antibody Development
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
IVD and Diagnostic Assay Manufacturers
Pharmaceutical and Biotechnology Companies
CROs and Biomarker Testing Service Providers
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Agilent Technologies, Inc.
Merck KGaA
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
Revvity, Inc.
Bio-Techne Corporation
Quanterix Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Protein Biomarkers Market, By Biomarker Type
- Global Protein Biomarkers Market, By Application
- Global Protein Biomarkers Market, By End User
- Global Protein Biomarkers Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Protein Biomarkers Market, By Biomarker Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cardiac Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Inflammatory and Sepsis Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurology Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Autoimmune Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Metabolic Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Protein Biomarkers Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biomarker Discovery and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Drug Discovery and Clinical Trial Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Assay Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antibody Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Protein Biomarkers Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
IVD and Diagnostic Assay Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
CROs and Biomarker Testing Service Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Protein Biomarkers Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profile
- Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Revvity, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Techne Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Quanterix Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies